NFH產(chǎn)品信息
別稱:NFH,Neurofilament heavy polypeptide
物種:Human
屬性:Protein
標(biāo)記:Unconjugated
內(nèi)毒素(Endotoxin)
Less than 1.0 EU per μg by the LAL method.
純度(Purity)
>95% as determined by SDS-PAGE.
制劑(Formulation)
Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.
Contact us for customized product form or formulation.
重構(gòu)方法(Reconstitution)
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
存儲(chǔ)(Storage)
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
-20°C to -70°C for 12 months in lyophilized state;
-70°C for 3 months under sterile conditions after reconstitution.
NFH分子背景
神經(jīng)絲(NF)被歸類為在神經(jīng)元細(xì)胞質(zhì)中發(fā)現(xiàn)的IV型中間絲。它們與微管和微絲一起形成神經(jīng)元細(xì)胞骨架。神經(jīng)絲通常含有三種中間絲蛋白:NFL、NFM和NFH,它們參與維持神經(jīng)元口徑。神經(jīng)絲光(NfL)是一種支架蛋白,主要位于有髓軸突內(nèi),提供更高的傳導(dǎo)速度和結(jié)構(gòu)支持。近年來,基于軸突損傷導(dǎo)致腦脊液或血液中NfL水平升高的觀察,NfL已被用作疾病生物標(biāo)志物。
關(guān)鍵字: NFH;NFH蛋白;NFH重組蛋白;ACRO;百普賽斯;
百普賽斯集團(tuán)ACROBiosystems Group(股票代碼:301080)是成立于2010年的跨國生物科技公司,是為全球生物醫(yī)藥、健康產(chǎn)業(yè)領(lǐng)域提供關(guān)鍵生物試劑產(chǎn)品及解決方案的行業(yè)平臺(tái)型基石企業(yè)。2021年在創(chuàng)業(yè)板上市。百普賽斯集團(tuán)業(yè)務(wù)遍布全球,橫跨亞洲、北美洲、歐洲,在中國、美國、瑞士等12個(gè)城市設(shè)有辦公室、研發(fā)中心及生產(chǎn)基地。目前累計(jì)服務(wù)客戶超6000家,與全球Top 20醫(yī)藥企業(yè)均建立了長期、穩(wěn)定的合作伙伴關(guān)系。集團(tuán)旗下?lián)碛衅放艫CROBiosystems百普賽斯、bioSeedin柏思薈、Condense Capital墾拓資本和ACRODiagnostics百斯醫(yī)學(xué)等。